| 1 |
18261274 | [Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up]. | 2007 Nov |
3 |
| 2 |
15157557 | Diagnosis and management of medullary thyroid carcinoma. | 2004 Mar |
1 |
| 3 |
15320968 | Frequency of RET proto-oncogene mutations in patients with normal and with moderately elevated pentagastrin-stimulated serum concentrations of calcitonin. | 2004 Aug |
1 |
| 4 |
11883863 | The finding of a somaticdeletion in RET exon 15 clarified the sporadic nature of amedullary thyroid carcinoma suspected to be familial. | 2002 Jan |
1 |
| 5 |
11289739 | Diagnosis and treatment of medullary thyroid cancer. | 2000 Dec |
1 |
| 6 |
9086571 | False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A. | 1997 Feb |
2 |
| 7 |
10462620 | Age-Related Disease Penetrance in a Large Medullary Thyroid Cancer Family With a Codon 609 RET Gene Mutation. | 1997 Dec |
1 |
| 8 |
8849576 | Genetic analysis of seven Mediterranean families with multiple endocrine neoplasia type 2A. | 1996 Feb |
1 |
| 9 |
8849577 | The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. | 1996 Feb |
4 |
| 10 |
8981015 | Application of genetic screening in families with hereditary medullary thyroid carcinoma. | 1996 |
1 |